fbpx

The synergistic anticancer effect of CBD and DOX in osteosarcoma

Osteosarcoma is a malignant tumor that can present with pain in the bones, joints, and local masses. The incidence is highest in adolescents, and the most common sites are the distal femur, proximal tibia and proximal humerus metaphyseal. Doxorubicin is the first-line chemotherapeutic agent for the treatment of osteosarcoma, but it has many side effects. Cannabidiol is a non-psychoactive plant cannabinoid cannabinol (CBD) that has been shown to be effective against osteosarcoma; however, the molecular targets and mechanisms of CBD action in osteosarcoma remain unclear.

The post The synergistic anticancer effect of CBD and DOX in osteosarcoma appeared first on Society of Cannabis Clinicians.

Leave a Reply

Generated by Feedzy
%d bloggers like this: